Promote Prescription Ophthalmic Products To U.S. Eyecare Professionals
March 13 (Reuters) - Eyenovia Inc EYEN.O :
* NOVABAY PHARMACEUTICALS AND EYENOVIA TO
CO-PROMOTE PRESCRIPTION
OPHTHALMIC PRODUCTS TO U.S. EYECARE PROFESSIONALS
* NOVABAY PHARMACEUTICALS INC - WILL MARKET EYENOVIA'S
CLOBETASOL
PROPIONATE OPHTHALMIC SUSPENSION 0.05% THROUGH ITS U.S.
PHYSICIAN-DISPENSED CHANNEL
* NOVABAY PHARMA - EYENOVIA TO MARKET CO'S PRESCRIPTION
AVENOVA
ANTIMICROBIAL LID & LASH SOLUTION THROUGH MYDCOMBI,CLOBETASOL
SALES REPRESENTATIVES
Source text for Eikon: ID:nGNX9xs8hR
Further company coverage: EYEN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing